Strength of Evidence:
4 out of 4
Year Published:
2012
Menopausal Hormone Therapy: Preventive Medication – Combined Estrogen and Progestin (Clinical Guide Recommendation)
Description of Resource:
The U.S. Preventive Services Task Force (USPSTF) recommends against the use of combined estrogen and progestin for the prevention of chronic conditions in postmenopausal women. This recommendation applies only to postmenopausal women who are considering hormone therapy for the primary prevention of chronic medical conditions. This recommendation is not about the use of hormone therapy to treat menopausal symptoms, such as hot flashes or vaginal dryness. USPSTF did not review the evidence related to this possible indication because it falls outside of the mission and scope of USPSTF. This recommendation also does not apply to women younger than age 50 who have had surgical menopause.
Developed By:
U.S. Preventive Services Task Force
Developer Type:
Federal Government
Healthy People 2020 Topic Area(s):
Maternal, Infant, and Child Health
Resource Type:
Citation:
U.S. Preventive Services Task Force. Menopausal Hormone Therapy: Preventive Medication recommendation statement [Internet]. 2012 Oct [cited 2014 Jan 8]. Available from: http://www.uspreventiveservicestaskforce.org/uspstf12/menohrt/menohrtfinalrstab1-2.htm
